menaquinone-7Finding
Menaquinone‑7 decreases serum undercarboxylated osteocalcin concentration
lowersVery limited evidenceFindingreplicated ×2
01 · The sentence it was drawn from
“Undercarboxylated osteocalcin decreased in the MK-7-group (- 65.2 ± 23.5%) (mean ± SD) compared with the placebo group (- 0.03 ± 38.5%), p < 0.01 after 1 year.”
menaquinone-7
Serum undercarboxylated osteocalcin concentration
lowers
- Who
- postmenopausal women with osteopenia, both arms receiving vitamin D3 38 µg/day and calcium 800 mg/day; result at 1 year of a 3-year trial
- Dose studied
- MK-7 375 µg once daily, added to vitamin D3 38 µg/day and calcium 800 mg/day given to both arms
Very limited evidencePMID 33030563 · 2021
02 · The study
- Study
- RCT
- Duration
- 12 months
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
Osteoporosis international04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7GJWT8562X4CS8XYPKBHG86